Literature DB >> 21365170

Telomere length in vascular tissues from patients with atherosclerotic disease.

R Nzietchueng1, M Elfarra, J Nloga, C Labat, J P Carteaux, P Maureira, P Lacolley, J P Villemot, A Benetos.   

Abstract

OBJECTIVES: The present study was aimed at evaluating telomere length in blood and in different vascular tissues with or without atheroma, in 3 groups of subjects: a group of atherosclerotic subjects who underwent surgery (Atherosclerosis-Surgery), a second group of subjects with asymptomatic atherosclerotic carotid plaques but who did not undergo cardiovascular surgery (Atherosclerosis-No surgery), and a third group of subjects without atherosclerotic disease (Controls). The main objective was to determine if there is in vivo regulation of telomere length in situ by atherosclerotic lesions.
METHODS: A total of 84 subjects (mean age 69 ± 8 years) were studied. Blood and arterial tissue telomere lengths were determined by Southern blotting. Personal medical history (diabetes, hypertension, cardiovascular disease, dyslipidemia), family medical history, drug intake, and lifestyle were evaluated in the entire population through the use of a questionnaire. RESULTS AND
CONCLUSION: Arterial segments which did not develop atherosclerosis such as the saphenous vein and internal mammary artery, had longer telomere length than aortic segments. On the other hand, telomere length was shorter in aortic tissues which presented atherosclerotic lesions compared to corresponding tissues without atherosclerotic lesions. These results also suggest tissue regulation of telomere size by local factors likely related to oxidative stress responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365170     DOI: 10.1007/s12603-011-0029-1

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  21 in total

1.  Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly.

Authors:  David J Kurz; Barbara Kloeckener-Gruissem; Alexander Akhmedov; Franz R Eberli; Ines Bühler; Wolfgang Berger; Osmund Bertel; Thomas F Lüscher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

2.  Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.

Authors:  Charles Matthews; Isabelle Gorenne; Stephen Scott; Nicola Figg; Peter Kirkpatrick; Andrew Ritchie; Martin Goddard; Martin Bennett
Journal:  Circ Res       Date:  2006-06-22       Impact factor: 17.367

3.  Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors.

Authors:  Guillaume Voghel; Nathalie Thorin-Trescases; Nada Farhat; Albert Nguyen; Louis Villeneuve; Aida M Mamarbachi; Annik Fortier; Louis P Perrault; Michel Carrier; Eric Thorin
Journal:  Mech Ageing Dev       Date:  2007-10-13       Impact factor: 5.432

4.  DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite.

Authors:  S Burney; J C Niles; P C Dedon; S R Tannenbaum
Journal:  Chem Res Toxicol       Date:  1999-06       Impact factor: 3.739

5.  Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction.

Authors:  Tohru Minamino; Hideaki Miyauchi; Toshihiko Yoshida; Yasuo Ishida; Hideo Yoshida; Issei Komuro
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

Review 6.  Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes.

Authors:  O Toussaint; E E Medrano; T von Zglinicki
Journal:  Exp Gerontol       Date:  2000-10       Impact factor: 4.032

7.  Telomere attrition in white blood cell correlating with cardiovascular damage.

Authors:  Hidekatsu Nakashima; Ryoji Ozono; Chizuko Suyama; Taijiro Sueda; Masayuki Kambe; Tetsuya Oshima
Journal:  Hypertens Res       Date:  2004-05       Impact factor: 3.872

8.  Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects.

Authors:  Athanase Benetos; Jeffrey P Gardner; Mahmoud Zureik; Carlos Labat; Lu Xiaobin; Chris Adamopoulos; Mohamed Temmar; Kathryn E Bean; Frédérique Thomas; Abraham Aviv
Journal:  Hypertension       Date:  2004-01-19       Impact factor: 10.190

9.  Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?

Authors:  T von Zglinicki; G Saretzki; W Döcke; C Lotze
Journal:  Exp Cell Res       Date:  1995-09       Impact factor: 3.905

10.  Telomere length in the newborn.

Authors:  Koji Okuda; Arlene Bardeguez; Jeffrey P Gardner; Paulette Rodriguez; Vijaya Ganesh; Masayuki Kimura; Joan Skurnick; Girgis Awad; Abraham Aviv
Journal:  Pediatr Res       Date:  2002-09       Impact factor: 3.756

View more
  18 in total

1.  Role of arterial telomere dysfunction in hypertension: relative contributions of telomere shortening and telomere uncapping.

Authors:  R Garrett Morgan; Stephen J Ives; Ashley E Walker; Richard M Cawthon; Robert H I Andtbacka; Dirk Noyes; Lisa A Lesniewski; Russell S Richardson; Anthony J Donato
Journal:  J Hypertens       Date:  2014-06       Impact factor: 4.844

Review 2.  The impact of hypertension on leukocyte telomere length: a systematic review and meta-analysis of human studies.

Authors:  M L Tellechea; C J Pirola
Journal:  J Hum Hypertens       Date:  2016-06-30       Impact factor: 3.012

Review 3.  Ageing induced vascular smooth muscle cell senescence in atherosclerosis.

Authors:  Anna K Uryga; Martin R Bennett
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

Review 4.  Vascular Smooth Muscle Cells in Atherosclerosis.

Authors:  Martin R Bennett; Sanjay Sinha; Gary K Owens
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

Review 5.  Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series.

Authors:  Michael N Sack; Frej Y Fyhrquist; Outi J Saijonmaa; Valentin Fuster; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

Review 6.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

Review 7.  Telomerase Therapy to Reverse Cardiovascular Senescence.

Authors:  Timo Z Nazari-Shafti; John P Cooke
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jul-Sep

Review 8.  The impact of oxidative DNA damage and stress on telomere homeostasis.

Authors:  Ryan P Barnes; Elise Fouquerel; Patricia L Opresko
Journal:  Mech Ageing Dev       Date:  2018-03-28       Impact factor: 5.432

Review 9.  Oxidative stress-induced telomeric erosion as a mechanism underlying airborne particulate matter-related cardiovascular disease.

Authors:  Thomas J Grahame; Richard B Schlesinger
Journal:  Part Fibre Toxicol       Date:  2012-06-19       Impact factor: 9.400

10.  Telomeres, oxidative stress, and myocardial infarction.

Authors:  Amir Rezvan
Journal:  Eur Heart J       Date:  2017-11-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.